
AstraZeneca bets on Asia: a surge of deals in March amid fraud probe
Newsletter Signup - Under Article / In Page "*" indicates required fields British pharma giant AstraZeneca, known for its cancer therapies Lynparza and Enhertu, among others, has signed deals on a number of research and development (R&D) …